Panel
Championing Innovation and ROI in Women's Health Care | Global Conference 2024
- The White House initiative is expected to transform investment in research areas spanning heart disease, Alzheimer's, and menopause management.
- Women's consumer power, combined with tech-enabled solutions like Maven and AI, is anticipated to accelerate access to necessary care.
- Adoption rates for community-owned solutions regarding diseases such as cervical cancer are projected to be significantly higher.
- The AHA's "research goes red" registry platform aims to upend clinical trial recruitment by leveraging a broad network of volunteers and hospitals, addressing the fact that fewer than 200 of the relevant hospitals in the "Get With The Guidelines" program are academic centers.
- A shift toward a data-driven system incorporating AI is expected to enhance the effectiveness of women's consumer power and care models.
- Directing money and investment into the hands of women is viewed as a catalyst for changing the women's health ecosystem.
- The menopausal company Midi Health is forecasted to experience astronomical growth driven by pent-up demand, specifically noting that 10,000 women turn 65 daily with no current solutions to meet their needs.
- Both Midi Health and Maven Clinic (Mitty) are expected to proceed with Initial Public Offerings (IPOs), signaling that the thesis that women's health generates returns is being proven.
- Momentum in Arkansas regarding a maternal health steering committee and investment case is expected to drive state focus on Medicaid reimbursement rates and other care levels, given that the state loses $2 billion annually due to adverse outcomes.
- Venture capital is identified as a primary engine for addressing the sector's incredible unmet needs.
- Investment in women's health is expected to grow as investors recognize the economic implications and the potential for financial returns.
- Public funding intended to subsidize research is anticipated to spur innovation and subsequent venture capital activity, following patterns observed in other sectors.
- The $250 million "food is medicine" initiative is expected to provide definitive evidence that such programs can improve health and reduce costs when integrated into healthcare.
- Despite current limitations where food-as-medicine access is restricted to those who can afford it, investments in meal delivery kits like CHEO are seen as opportunities to make healthcare accessible for all.
- Addressing women's health inequities is expected to raise the average life expectancy for women from the current 79 years to 82 years.
- Future medicine is projected to become personalized based on underlying genetics, potentially reducing the necessity for specific gender distinctions in treatment.
- Virtual care is expected to facilitate the rebuilding of trust in the healthcare system within communities of color.
- Tens of billions in additional innovation in menopause are anticipated if dedicated women's health investors can secure funding, noting that current dedicated management is less than one billion dollars.